Javascript must be enabled to continue!
Insulin treatment exerts cardioprotective effect against reperfusion injury via inhibiting early reperfusion-induced CaMKII activation
View through CrossRef
Objectives
Primary reperfusion therapies, including percutaneous coronary intervention (PCI) and thrombolysis, are the standard of care for treating myocardial infarction (MI). Paradoxically, however, the return of blood flow can also result in additional damage and complications, referred to as reperfusion injury. In ischemic/reperfused (I/R) heart, Ca2+/calmodulin-dependent protein kinase II (CaMKII) activation has been implicated in triggering apoptotic signaling. We have previously found that insulin reduces I/R injury, but the mechanisms remain elusive. The present study was designed to determine whether early insulin treatment reduces the myocardial reperfusion injury at the onset of R and its mechanisms.
Methods and Results
Male adult SD rats were subjected to 30 min of MI followed by 3 h of R. A significant activation of CaMKII at 3 min of R was confirmed by increased phosphorylation of both CaMKII (1.4-fold) and PLBThr17 (9.7-fold). Insulin treatment (0.4U/kg/h, administrated 10 min before MI and during the first 10 min of R, intravenous) notably improved PI3K expression and pAkt/Akt ratio (p<0.01 vs Saline) and inhibited CaMKII activity at 3 min of R (pCaMKII/CaMKII, pPLBThr17/PLB, both p<0.01). At the end of 3 h of R, insulin group exhibited reduced I/R injury as evidenced by decreased apoptosis (TUNEL and activated caspase 3) and improved left ventricular developed pressure recovery (LVDP: 77.2%±2.9% vs 65.3%±2.5%, all p<0.05). Pretreatment with wortmannin partially abolished insulin's inhibition of CaMKII activity (p<0.01) and its reduction of reperfusion injury (decreased TUNEL, activated caspase 3 and increased LVDP, all p<0.05).
Conclusion
These data are the first to demonstrate that insulin inhibits CaMKII in the beginning of reperfusion, at least in part, through PI3K-Akt signaling and reduces reperfusion injury, which suggests that early insulin therapy when reperfusion is clinically performed exerts significant cardioprotection.
Title: Insulin treatment exerts cardioprotective effect against reperfusion injury via inhibiting early reperfusion-induced CaMKII activation
Description:
Objectives
Primary reperfusion therapies, including percutaneous coronary intervention (PCI) and thrombolysis, are the standard of care for treating myocardial infarction (MI).
Paradoxically, however, the return of blood flow can also result in additional damage and complications, referred to as reperfusion injury.
In ischemic/reperfused (I/R) heart, Ca2+/calmodulin-dependent protein kinase II (CaMKII) activation has been implicated in triggering apoptotic signaling.
We have previously found that insulin reduces I/R injury, but the mechanisms remain elusive.
The present study was designed to determine whether early insulin treatment reduces the myocardial reperfusion injury at the onset of R and its mechanisms.
Methods and Results
Male adult SD rats were subjected to 30 min of MI followed by 3 h of R.
A significant activation of CaMKII at 3 min of R was confirmed by increased phosphorylation of both CaMKII (1.
4-fold) and PLBThr17 (9.
7-fold).
Insulin treatment (0.
4U/kg/h, administrated 10 min before MI and during the first 10 min of R, intravenous) notably improved PI3K expression and pAkt/Akt ratio (p<0.
01 vs Saline) and inhibited CaMKII activity at 3 min of R (pCaMKII/CaMKII, pPLBThr17/PLB, both p<0.
01).
At the end of 3 h of R, insulin group exhibited reduced I/R injury as evidenced by decreased apoptosis (TUNEL and activated caspase 3) and improved left ventricular developed pressure recovery (LVDP: 77.
2%±2.
9% vs 65.
3%±2.
5%, all p<0.
05).
Pretreatment with wortmannin partially abolished insulin's inhibition of CaMKII activity (p<0.
01) and its reduction of reperfusion injury (decreased TUNEL, activated caspase 3 and increased LVDP, all p<0.
05).
Conclusion
These data are the first to demonstrate that insulin inhibits CaMKII in the beginning of reperfusion, at least in part, through PI3K-Akt signaling and reduces reperfusion injury, which suggests that early insulin therapy when reperfusion is clinically performed exerts significant cardioprotection.
Related Results
Huoxue Wentong Formula ameliorates myocardial infarction in rats through inhibiting CaMKII oxidation and phosphorylation
Huoxue Wentong Formula ameliorates myocardial infarction in rats through inhibiting CaMKII oxidation and phosphorylation
Abstract
Background
The Chinese medicine Huoxue Wentong Formula (HXWTF) was used to treat thoracic obstruction and angina pectoris in clinic, which has not been investigated in myo...
New and simple Ohmic definition of insulin resistance in lean and obese subjects
New and simple Ohmic definition of insulin resistance in lean and obese subjects
objective:: Insulin enhances the influx of glucose into cells. However, the relationship between glucose and insulin is complex and insulin sensitivity varies widely with age, ethn...
A Case of Insulin Resistance Secondary to Insulin Induced Localized Cutaneous Amyloidosis.
A Case of Insulin Resistance Secondary to Insulin Induced Localized Cutaneous Amyloidosis.
Abstract
Abstract 4908
Insulin resistance can be a major problem in patients with diabetes mellitus. Although multiple reasons can result in this prob...
P3832Dantrolene reduces CaMKII-mediated arrhythmogenesis
P3832Dantrolene reduces CaMKII-mediated arrhythmogenesis
Abstract
Rationale
In atrial and ventricular rhythm disorders, an increased diastolic sarcoplasmatic reticulum (SR) calcium leak...
Tao‐Hong‐Si‐Wu decoction reduces ischemia reperfusion rat myoblast cells calcium overloading and inflammation through the Wnt/IP3R/CAMKII pathway
Tao‐Hong‐Si‐Wu decoction reduces ischemia reperfusion rat myoblast cells calcium overloading and inflammation through the Wnt/IP3R/CAMKII pathway
AbstractLimb ischemia reperfusion (LIRI) injury is associated with serious local and systemic effects. Reperfusion may augment tissue injury in excess of that produced by ischemia ...
IL‐1β induces MMP‐9 expression via a Ca2+‐dependent CaMKII/JNK/c‐JUN cascade in rat brain astrocytes
IL‐1β induces MMP‐9 expression via a Ca2+‐dependent CaMKII/JNK/c‐JUN cascade in rat brain astrocytes
AbstractInterleukin (IL)‐1β has been shown to induce matrix metalloproteinase (MMP)‐9 expression through mitogen‐activated protein kinases, including JNK, in rat brain astrocyte‐1 ...
KELCH-3 (KLHL3): A Potential Regulator of Insulin-Induced Renal
Haemodynamic Alterations in Obesity
KELCH-3 (KLHL3): A Potential Regulator of Insulin-Induced Renal
Haemodynamic Alterations in Obesity
Background: The contribution of elevated insulin levels to renal
disease in pre-diabetic obesity remains underappreciated, as glomerular
...
Pulmonary reperfusion injury in post-palliative intervention of oligaemic cyanotic CHD: a new catastrophic consequence or just revisiting the same old story?
Pulmonary reperfusion injury in post-palliative intervention of oligaemic cyanotic CHD: a new catastrophic consequence or just revisiting the same old story?
AbstractPulmonary reperfusion injury is a well-recognised clinical entity in the setting pulmonary artery angioplasty for pulmonary artery stenosis or chronic thromboembolic diseas...

